Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Spondylitis, Ankylosing × Sulfasalazine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Glioblastoma 2 Spondylitis, Ankylosing 1 Signs and Symptoms 1 Lymphoma 1 Leukemia, Myeloid, Acute 1 Glioma 1 Epilepsy 1 Diarrhea 1 Colorectal Neoplasms 1 Breast Neoplasms 1 Brain Neoplasms 1 Arthritis, Rheumatoid 1

Interventions

Adalimumab 4 tocilizumab 1 secukinumab 1 golimumab 1 Vaccines 1 Tumor Necrosis Factors 1 Tai Ji 1 Sulfasalazine 1 Sodium Chloride 1 Saline Solution 1 Pamidronate 1 Meloxicam 1 Herpes Zoster Vaccine 1 Exercise 1 Etoricoxib 1 Etanercept 1 Celecoxib 1 Anti-Inflammatory Agents, Non-Steroidal 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02456363 2015-05-28

Anti-Tumor Necrosis Factor Therapy In Patients With Ankylosing Spondylitis

Chung Shan Medical University

Phase 2 Unknown

Spondylitis, Ankylosing

Data powered by HemOnc (CC BY 4.0) Colophon ⚡